Stock 6090 HUMAN METABOLOME TECHNOLOGIES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Human Metabolome Technologies, Inc.

Equities

6090

JP3794530000

Delayed Japan Exchange
Other stock markets
 02:00:00 2024-05-02 am EDT 		5-day change 1st Jan Change
645 JPY -0.77% Intraday chart for Human Metabolome Technologies, Inc. -2.57% +0.78%
Feb. 14 Human Metabolome Technologies, Inc. Provides Dividend Guidance for the Year Ending June 2024 CI
2023 Human Metabolome Technologies, Inc. Provides Consolidated Earnings Guidance for the Year Ending June 30, 2024 CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Human Metabolome Technologies, Inc. Provides Dividend Guidance for the Year Ending June 2024
CI
Human Metabolome Technologies, Inc. Provides Consolidated Earnings Guidance for the Year Ending June 30, 2024
CI
Human Metabolome Technologies, Inc. Announces Year End Dividend for the Year Ended June 30, 2023, Payable on September 7, 2023; Provides Year End Dividend Guidance for the Year Ending June 30, 2024
CI
Human Metabolome Technologies, Inc. Reports Earnings Results for the Nine Months Ended March 31, 2023
CI
Human Metabolome Technologies, Inc. Provides Consolidated Earnings Guidance for the Fiscal Year Ending June 2023
CI
Human Metabolome Technologies, Inc. Provides Dividend Guidance for the Year Ending June 2023
CI
Human Metabolome Technologies, Inc. Provides Consolidated Earnings Guidance for the Fiscal Year Ending June 30, 2023
CI
Human Metabolome Technologies, Inc. Provides Consolidated Earnings Guidance for the Year Ending June 2023
CI
Human Metabolome Technologies, Inc. Provides Consolidated Earnings Guidance for the Year Ending June 2023
CI
Human Metabolome Technologies, Inc. Provides Earnings Guidance for the Full Year Ending June 2022
CI
Human Metabolome Technologies, Inc. Provides Consolidated Earnings Guidance for the Year Ending June 30, 2022
CI
Human Metabolome Technologies, Inc. Provides Consolidated Earnings Guidance for the Year Ending June 30, 2022
CI
Human Metabolome Technologies : Summary of Financial Results 2021
PU
Human Metabolome Technologies, Inc. Announces Consolidated Earnings Results for the Fourth Quarter Ended June 2021
CI
Human Metabolome Technologies, Inc. Provides Consolidated Earnings Guidance for the Year Ending June 30, 2022
CI
Human Metabolome Technologies : Summary of Financial Results for the third quarter 2021
PU
Human Metabolome Technologies, Inc. Announces Consolidated Earnings Results for the Third Quarter Ended March 2021
CI
Human Metabolome Technologies, Inc. Announces Consolidated Earnings Results for the Second Quarter Ended December 2020
CI
Human Metabolome Technologies, Inc. Provides Consolidated Earnings Guidance for the Year Ending June 30, 2021
CI
Human Metabolome Technologies, Inc. Announces Financial Results for the Quarter Ended September 2020
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 6090 Stock
  4. News Human Metabolome Technologies, Inc.